Antidote Therapeutics, Inc.

Biotechnology company · Gaithersburg, Maryland, United States

Antidote Therapeutics, Inc. is a biotechnology company headquartered in Gaithersburg, Maryland, United States. Its earliest recorded incorporation is in 2013. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $200,834 in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $200,000 sold in a notice filed in 2017.

Profile compiled from public records. Is this your company? Request a correction or update

Antidote Therapeutics at a glance

Typebiotechnology company
HeadquartersGaithersburg, Maryland, United States
Earliest incorporation on record2013
Employees (self-reported, 2017)1
SEC CIK1716110

What does Antidote Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $200,834 in total (2017). NIH funding came from the National Institute on Drug Abuse.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $200,000 sold (2017).

Frequently asked questions about Antidote Therapeutics

Where is Antidote Therapeutics headquartered?

Antidote Therapeutics, Inc. is headquartered in Gaithersburg, Maryland, United States.

What does Antidote Therapeutics do?

Antidote Therapeutics, Inc. is a biotechnology company.

When was Antidote Therapeutics founded?

The earliest incorporation on record for Antidote Therapeutics, Inc. is in 2013, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences